Advertisement

Topics

Qkine signs deal to drive stem cell and regenerative medicine research

20:00 EDT 31 Jul 2017 | AAAS

(University of Cambridge) Cambridge Enterprise, the commercialization arm of the University of Cambridge, and specialist growth factor manufacturer Qkine Ltd have signed a key licensing deal for Activin A production technology.

Original Article: Qkine signs deal to drive stem cell and regenerative medicine research

NEXT ARTICLE

More From BioPortfolio on "Qkine signs deal to drive stem cell and regenerative medicine research"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...